Full-Time

Analytical R&D Manager

Granules

Granules

501-1,000 employees

Vertically integrated API and dosage manufacturer

Compensation Overview

$100k - $130k/yr

Chantilly, VA, USA

In Person

Bachelor's, Master's, PhD

Category
Biology & Biotech (2)
,
Required Skills
GMP
Quality Assurance (QA)

Get referred to Granules

See people who can refer or advise you

Requirements
  • A Bachelor's degree in Analytical Chemistry or Chemistry or a related field with 10 or more years of GMP- and GLP-related pharmaceutical industry experience in small-molecule solid oral formulation analytical development, or an MS/PhD with 7 or more years of that experience.
  • Knowledge of active pharmaceutical ingredients, excipients, and finished products in generic pharmaceuticals.
  • Hands-on experience with analytical techniques including high-performance liquid chromatography, gas chromatography, Karl Fischer, mass spectrometry, dissolution, spectroscopy, and particle size analysis.
  • Functional understanding of small-molecule analytical development and associated regulatory and quality requirements.
  • In-depth understanding of good manufacturing practices and applicable CMC, analytical, and manufacturing regulatory guidance.
  • Ability to stand for long periods of time, maneuver at least 40 pounds, wear a respirator, pass associated respirator tests or requirements, and wear all required personal protective equipment.
  • Ability to see details at close range.
Responsibilities
  • Manage day-to-day laboratory operations and supervise the group's daily activities.
  • Plan and execute method development, method validation, and technology transfer activities for active pharmaceutical ingredients, excipients, package components, and finished products.
  • Oversee analytical techniques, interpretation of analytical data, problem solving, and troubleshooting for Analytical R&D activities.
  • Prepare and review standard operating procedures, protocols, and reports to support laboratory good manufacturing practices compliance with FDA, ICH, and other regulatory guidance.
  • Plan and manage in-process release testing for exhibit batches and coordinate stability testing with Quality Control.
  • Plan, review, and implement additional studies, including cleaning validation, extractables and leachables, elemental impurity, residual solvent, nitrosamine, photostability, in-use, multimedia dissolution, and shipping studies.
  • Use project-management techniques and maintain planning tools such as spreadsheets and Microsoft Project for Analytical R&D project activities.
  • Communicate with outside vendors and contract laboratories and plan and execute outside-laboratory testing.
  • Work with the Product Development team to manage and coordinate analytical activities on development samples.
  • Plan and design experiments to address CMC deficiency responses.
  • Collaborate with Product Development, Regulatory Affairs, Quality Assurance, Quality Control, contract laboratories, and Supply Chain to support new product development, ANDA submissions, and commercial launches.
  • Review pharmaceutical product development reports, quality overall summaries, and other documents required to support ANDA regulatory filings.
  • Investigate out-of-trend results, out-of-specification results, and laboratory deviations, and propose and implement corrective and preventive actions.
  • Manage the Analytical R&D laboratory function to ensure cGMP compliance.
  • Provide timely reports, interpret analytical data, and present results to the department head and R&D head.
  • Review staff performance regularly and develop team members to improve individual and team performance.

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours